Methotrexate and the photodermatitis reactivation reaction: A case report and review of the literature

Cutis

Volumn 66, Issue 5, 2000, Pages 379-382

  Khan, Azim J ^a   Marghoob, Ashfaq A ^b   Prestia, Alan E ^c   Spector, Ira J ^c,d  

^a STONY BROOK UNIVERSITY   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c Huntington Medical Group   (United States)

^d Department of Dermatology ^*

Author keywords

[No Author keywords available]

Indexed keywords

ABORTIVE AGENT; METHOTREXATE;

ADULT; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; FEMALE; HUMAN; PHOTOSENSITIVITY DISORDER; POSTOPERATIVE PERIOD; PREGNANCY; RECURRENT DISEASE; TIME; UTERINE TUBE PREGNANCY;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ADULT; FEMALE; HUMANS; METHOTREXATE; PHOTOSENSITIVITY DISORDERS; POSTOPERATIVE PERIOD; PREGNANCY; PREGNANCY, TUBAL; RECURRENCE; TIME FACTORS;

EID: 0034329981     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Wolverton SE, Wilkin JK. Systemic Drugs for Skin Diseases. Philadelphia, Pa: WB Saunders Co; 1991.
2. Alexander JM, Rouse DJ, Varner E, et al. Treatment of the small unruptured ectopic pregnancy: a cost analysis of methotrexate versus laparoscopy. Obstet Gynecol. 1996;88:123-127.
3. Stika CS, Anderson L, Frederiksen MC. Single-dose methotrexate for the treatment of ectopic pregnancy. Northwestern Memorial Hospital three-year experience. Am J Obstet Gynecol. 1996;174:1840-1846.
4. Korossy KS, Hood AF. Methotrexate reactivation of sunburn reaction. Arch Dermatol. 1981;117:310-311.
5. Zurcher K, Krebs A. Cutaneous Drug Reactions: An Integral Synopsis of Today's Systemic Drugs. Basel, Switzerland: S Karger Publishing; 1992.
6. Roenigk HH, Fowler-Bergfeld W, Curtis GH. Methotrexate for psoriasis in weekly oral doses. Arch Dermatol. 1969;99: 86-93.
7. Yokel BK, Hood AF. Mucocutaneous complications of antineoplastic therapy. In: Fitzpatrick TB, Eisen AZ, Wolff K, et al, eds. Dermatology in General Medicine. 4th ed. New York, NY: McGraw-Hill; 1993:1795-1806.
8. Harber LC. Abnormal responses to ultraviolet radiation: drug induced photosensitivity. In: Fitzpatrick TB, Eisen AZ, Wolff K, et al, eds. Dermatology in General Medicine. 4th ed. New York, NY: McGraw-Hill; 1993:1677.
9. Morison WL, Momtaz K, Parrish JA, et al. Combined methotrexate - PUVA therapy in the treatment of psoriasis. J Am Acad Dermatol. 1982;6:46-51.
10. Champion RH, Burton JL, Ebling FJG. Textbook of Dermatology. 5th ed. London, England: Blackwell Scientific Publications; 1992.
11. Kim YH, Aye MS, Fayos JV. Radiation necrosis of the scalp: a complication of cranial irradiation and methotrexate. Ther Radiol. 1977;124:813-814.
12. Bork K. Cutaneous Side Effects of Drugs. Philadelphia, Pa: WB Saunders Co; 1988.
13. Weiss RB, James WD, Major WB, et al. Skin reactions induced by trimetrexate, an analog of methotrexate. Invest New Drugs. 1986;4:159-163.
14. Okamoto H, Fukuda A, Mizuno K, et al. Reactivation of phototoxicity test for psoralens plus ultraviolet A by low-dose methotrexate. Photodermatol Photoimmunol Photomed. 1994;10:134-136.
15. Paul BS, Momtaz TK, Stern RS, et al. Combined methotrexate-ultraviolet B therapy in the treatment of psoriasis. J Am Acad Dermatol. 1982;7:758-762.
16. Guzzo C, Kaidby K. Recurrent recall of sunburn by methotrexate. Photodermatol Photoimmunol Photomed. 1995;11:55-56.
17. Vogler WR, Huguley CM, Kerr W. Toxicity and antitumor effects of divided doses of methotrexate. Arch Intern Med. 1965;115:285-293.
18. Moller H. Reactivation of acute inflammation by methotrexate. J Invest Dermatol. 1969;52:437-441.
19. Lawrenz-Wolf B, Wehinger H. Zur Reaktivierung von sonnenbranden durch methorexat. Klin Padiatr. 1988;200:335-338.
20. Nedorost ST, Dijkstra JWE, Handel DW. Drug-induced photosensitivity reaction. Arch Dermatol. 1989;125:433-434.
21. Mallory SB, Berry DH. Severe reactivation of sunburn following methotrexate use. Pediatrics. 1986;78:514-515.
22. Moller H. Methotrexate and the ultraviolet light inflammation in the guinea pig. Dermatologica. 1970;140:225-230.
23. Armstrong RB, Poh-Fitzpatrick MB. Methotrexate and ultraviolet radiation. Arch Dermatol. 1982;118:177-178.
24. LeVine MJ. Erythema resulting from suberythemogenic doses of ultraviolet radiation and methotrexate. Arch Dermatol. 1981;117:656-658.
25. Andersen KE, Lindskov R. Recall of UVB-induced erythema in breast cancer patient receiving multiple drug chemotherapy. Photodermatology. 1984;1:129-132.
26. Jaffe N, Paed D, Farber S, et al. Favorable response of metastatic osteogenic sarcoma to pulse high-dose methotrexate with citrovorum rescue and radiation therapy. Cancer. 1973;31:1367-1373.
27. Rosen G, Tefft M, Martinez A, et al. Combination chemotherapy and radiation therapy in the treatment of metastatic osteogenic sarcoma. Cancer. 1975;35:622-630.
28. Westwick TJ, Sherertz E, McCarley D, et al. Delayed reaction of sunburn by methotrexate sparing of chronically sun-exposed skin. Cutis. 1987;39:49-51.
29. Corder MP, Stone WH. Failure of leukovorin rescue to prevent reactivation of a solar burn after high dose methotrexate. Cancer. 1976;37:1660-1662.
30. Jaffe N. Reactivation of a solar burn with high-dose methotrexate and citrovorum rescue [letter] Cancer. 1976;38:1036-1037.
31. Vogler WR, Jacobs J. Toxic and therapeutic effects of methotrexate-folinic acid (leukovorin) in advanced cancer and leukemia. Cancer. 1971;28:894-900.
32. Epstein JH, Fukuyama K, Fye K. Effects of ultraviolet radiation on the mitotic cycle and DNA, RNA, and protein synthesis in mammalian epidermis in vivo. Photochem Photobiol. 1970;12:57-65.
33. Neiman RA, Fye KH. Methotrexate induced false photo-sensitivity reaction. J Rheumatol. 1985;12:354-355.